Astellas, Tmunity, Underscore Rocky Terrain of CAR-T and Gene Therapies

Deaths associated with Astellas Pharma’s gene therapy program for patients with X-linked Myotubular Myopathy underscore some of the risks of developing potential one-and-done treatment options for serious diseases.